BAXALTA US INC. for BAXALTA US INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
International tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| JED PERRY | — |
Trade (domestic/foreign) TRD
FDA rules regarding information requirements for importation of FDA-regulated products
| Lobbyist | Covered position, as disclosed |
|---|---|
| JED PERRY | — |
Copyright/Patent/Trademark CPT
H.R. 9, the Innovation Act: To amend title 35, United States Code, and the Leahy-Smith America Invents Act to make improvements and technical corrections, and for other purposes. S. 1137, the Protecting American Talent and Entrepreneurship Act of 2015. A bill to amend title 35, United States Code, and the Leahy-Smith America Invents Act to make improvements and technical corrections, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JED PERRY | — |
Medicare/Medicaid MMM
S. 275/HR. 605: Medicare Home Infusion Site of Care Act of 2015 Amends title XVIII (Medicare) of the Social Security Act to authorize Medicare coverage of home infusion therapy and home infusion drugs. Directs the Secretary of Health and Human Services to implement the Medicare home infusion therapy benefit in a manner that ensures that: (1) Medicare beneficiaries have timely and appropriate access to infusion therapy in their homes, and (2) there is rapid and seamless coordination between drug coverage under Medicare part D (Voluntary Prescription Drug Benefit Program) and home infusion therapy services coverage under Medicare part B (Supplemental Security Income) (SSI) to avoid the filing of duplicative or otherwise improper claims. Medicare coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| LEO KIM | — |
| MARGARET NOWAK | — |
| JED PERRY | — |
Health Issues HCR
H.R. 6, the 21st Century Cures Act: To accelerate the discovery, development, and delivery of 21st century cures, and for other purposes. 340B Drug Discount Program Orphan Drug Act Biosimilars Gene Therapy Drug Pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| ENGEL BURNS | — |
| LEO KIM | — |
| MARGARET NOWAK | — |
| JED PERRY | — |
Foreign Relations FOR
Article 29 Working Party on the Protection of Individuals (WP29) statement regarding the landmark CJEU ruling invalidating Safe Harbor as a mechanism of establishing adequacy supporting EU-US data transfers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JED PERRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.